Drug
liposomal curcumin
liposomal curcumin is a pharmaceutical drug with 5 clinical trials. Historical success rate of 100.0%.
Total Trials
5
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 5 completed trials
Completion Rate
100%(5/5)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph not_applicable
2
40%
Ph phase_4
1
20%
Ph phase_3
1
20%
Ph phase_1
1
20%
Phase Distribution
1
Early Stage
0
Mid Stage
2
Late Stage
Phase Distribution5 total trials
Phase 1Safety & dosage
1(20.0%)
Phase 3Large-scale testing
1(20.0%)
Phase 4Post-market surveillance
1(20.0%)
N/ANon-phased studies
2(40.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
100.0%
5 of 5 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
5
all time
Status Distribution
Completed(5)
Detailed Status
Completed5
Development Timeline
Analytics
Development Status
Total Trials
5
Active
0
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 11 (20.0%)
Phase 31 (20.0%)
Phase 41 (20.0%)
N/A2 (40.0%)
Trials by Status
completed5100%
Recent Activity
0 active trials
Showing 5 of 5
completedphase_4
Effectiveness of Curcuminoids in Controlling Postoperative Pain Following Total Laparoscopic Hysterectomy
NCT06886035
completedphase_3
High-protein Oral Supplement With Liposomal Curcumin in Adults Undergoing Hemodialysis.
NCT06381076
completednot_applicable
A Study of Curcumin (Soloways ™) in Patients With Inflammatory Bowel Disease Homozygous for the IL-10 Variant
NCT06867939
completednot_applicable
Comparison of Curcumin Bioavailability
NCT03530436
completedphase_1
Evaluation of Liposomal Curcumin in Healthy Volunteers
NCT01403545
Clinical Trials (5)
Showing 5 of 5 trials
NCT06886035Phase 4
Effectiveness of Curcuminoids in Controlling Postoperative Pain Following Total Laparoscopic Hysterectomy
NCT06381076Phase 3
High-protein Oral Supplement With Liposomal Curcumin in Adults Undergoing Hemodialysis.
NCT06867939Not Applicable
A Study of Curcumin (Soloways ™) in Patients With Inflammatory Bowel Disease Homozygous for the IL-10 Variant
NCT03530436Not Applicable
Comparison of Curcumin Bioavailability
NCT01403545Phase 1
Evaluation of Liposomal Curcumin in Healthy Volunteers
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5